|
|
Emtriva (Emtricitabine, FTC)
| Brand Name: |
Emtriva |
| Generic Name: |
Emtricitabine, FTC |
| Adult Single Dose: |
One 200-mg capsule (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
The Basics
- An Overview of Emtriva (Emtricitabine) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Emtricitabine (Emtriva) (August 22, 2009)
To read PDF, click here
From AIDS InfoNet
- Emtriva (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Patient Information About Emtriva (Emtricitabine, FTC) (PDF) (May 2008)
From Gilead Sciences, Inc.
- Emtriva (Emtricitabine, FTC) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- FTC (Emtricitabine, Emtriva) (August 15, 2006)
From AIDS Treatment Data Network
- Emtriva (Emtricitabine) (November 2005)
[Archived Article]
To read PDF, click here
From The Center for AIDS
- Labeling Changes for Emtriva (September 28, 2005)
[Archived Article]
Specific modifications since the label was last updated are highlighted.
From U.S. Food and Drug Administration
- Three New Drugs Approved by FDA (November/December 2003)
[Archived Article]
An overview of Fuzeon (enfuvirtide, T-20), Reyataz (atazanavir) and Emtriva (emtricitabine, FTC).
In Survival News, from AIDS Survival Project
- Access Information for T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
[Archived Article]
How to get information about receiving these new HIV medications through ADAPs and Patient Assistance Programs.
To read PDF, click here
In Project Inform Perspective, from Project Inform
- The Bottom Line on T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
[Archived Article]
Bare-bones highlights of three of this year's new HIV medications.
To read PDF, click here
In Project Inform Perspective, from Project Inform
- Approval of Emtriva for Treating HIV (July 2, 2003)
[Archived Article]
From U.S. Food and Drug Administration
- FTC Has Been Approved: What Now? (July 2003)
[Archived Article]
An analysis of what we know so far -- and what we have yet to learn.
In TAGline, from Treatment Action Group
- Separated at Birth: 3TC and FTC (July 2003)
[Archived Article]
A quick comparison of molecular structures.
In TAGline, from Treatment Action Group
- FTC: Once-Daily Mate for Tenofovir? (April 2003)
[Archived Article]
A summary of study results from CROI 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Anti-HIV Drug Updates: Emtricitabine (FTC, Coviracil) (January 2003)
[Archived Article]
In Project Inform Perspective, from Project Inform
- New Anti-HIV Therapies: Emtricitabine (January 2003)
[Archived Article]
From Project Inform
Research
- Clinical Trials Using Emtricitabine (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health
- Literature Citations for Emtricitabine (Regularly Updated)
From U.S. National Institutes of Health
- Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- Emtriva: New Pediatric Formulation and Labeling Changes (September 28, 2005)
[Archived Article]
From U.S. Food and Drug Administration
- Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine (February 25, 2005)
[Archived Article]
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
- Food and Drug Administration to Expedite Decision on Emtricitabine/Tenofovir Pill (May 18, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Emtricitabine: A New Nucleoside Analogue for Once-Daily Antiretroviral Therapy (January 2004)
[Archived Article]
In Expert Opinion on Investigational Drugs
- No PK Interaction Seen Between FTC and AZT or Tenofovir (September 16, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- FTC Compares Well to 3TC in Triple-NRTI Regimens (September 15, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- FTC Similar in Most Ways to 3TC (September 15, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- A New Once a Day Nucleoside: Emtriva -- A New Option in Once Daily HIV Therapy (August 12, 2003)
[Archived Article]
In STEP Ezine, from Seattle Treatment Education Project
- FTC (Emtriva) Approved (July 25, 2003)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Phase III Results of FTC in Hepatitis B and HIV Co-Infected Patients (July 16, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Comparison of Once-Daily FTC Vs. Twice-Daily Abacavir in a Regimen for Drug-Naive Patients (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Forty-Eight Week Data From FTC-d4T Comparison in Treatment-Naive Patients (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- FTC Potent Within a HAART Regimen in Treatment-Naive HIV-Infected Patients With High Viral Loads (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Incidence of Symptomatic Hyperlactatemia With FTC (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir (July 3, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Anti-HIV Drug Updates -- Three Drugs on the Near Horizon (January 2003)
[Archived Article]
Research from Barcelona on T-20, atazanavir and emtricitabine.
To read PDF, click here
In Project Inform Perspective, from Project Inform
- Coviracil (FTC) Enters the Home Stretch (December 2002)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Research From the 42nd ICAAC: A Nucleoside (FTC) and a Nucleotide (Tenofovir) Outdo d4T (December 2002)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Drug Company Gets Good News on FTC, Bad News on DAPD (September 2002)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- FTC Superiority Over d4T in Phase III Trial (September/October 2002)
[Archived Article]
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
- Coviracil (FTC) Trial Unblinded Early Due to Drug's Superiority (July/August 2002)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Long-Term Efficacy and Safety of Emtricitabine (FTC) in HIV-Positive Adults Switching from a Lamivudine (3TC)-Containing HAART Regimen (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
|
Advertisement
|
E-Mail
Glossary
Share